Back to Journals » Neuropsychiatric Disease and Treatment » Volume 14

Neuropsychiatric Disease and Treatment


Archive: Volume 14, 2018

Neuropsychiatric assessments in patients with multiple sclerosis in early phases and with low disability

Schmidt SL, Santos da Silva M, Schmidt JJ, Carvalho ALN, Vasconcelos CCF, Paes RA, Boechat YEM, Neder R, Alvarenga RP

Neuropsychiatric Disease and Treatment 2018, 14:1665-1670

Published Date: 22 June 2018

COMT Val 108/158 Met polymorphism and treatment response to aripiprazole in patients with acute schizophrenia

Kaneko H, Miura I, Kanno-Nozaki K, Horikoshi S, Hino M, Yabe H

Neuropsychiatric Disease and Treatment 2018, 14:1657-1663

Published Date: 22 June 2018

The detection of white matter alterations in obsessive–compulsive disorder revealed by TRActs Constrained by UnderLying Anatomy (TRACULA)

Watanabe A, Nakamae T, Sakai Y, Nishida S, Abe Y, Yamada K, Yokota I, Narumoto J

Neuropsychiatric Disease and Treatment 2018, 14:1635-1643

Published Date: 19 June 2018

The role of MAPT gene in Chinese dementia patients: a P301L pedigree study and brief literature review

He S, Chen S, Xia MR, Sun ZK, Huang Y, Zhang JW

Neuropsychiatric Disease and Treatment 2018, 14:1627-1633

Published Date: 18 June 2018

Vibration therapy in patients with cerebral palsy: a systematic review

Ritzmann R, Stark C, Krause A

Neuropsychiatric Disease and Treatment 2018, 14:1607-1625

Published Date: 18 June 2018

Mindfulness-based cognitive therapy in patients with depression: current perspectives

MacKenzie MB, Abbott KA, Kocovski NL

Neuropsychiatric Disease and Treatment 2018, 14:1599-1605

Published Date: 18 June 2018

Structural equation modeling approach between salience network dysfunction, depressed mood, and subjective quality of life in schizophrenia: an ICA resting-state fMRI study

Ohta M, Nakataki M, Takeda T, Numata S, Tominaga T, Kameoka N, Kubo H, Kinoshita M, Matsuura K, Otomo M, Takeichi N, Harada M, Ohmori T

Neuropsychiatric Disease and Treatment 2018, 14:1585-1597

Published Date: 15 June 2018

Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations

Mayerova M, Ustohal L, Jarkovsky J, Pivnicka J, Kasparek T, Ceskova E

Neuropsychiatric Disease and Treatment 2018, 14:1535-1543

Published Date: 14 June 2018

Risk assessment of night-eating syndrome occurrence in women in Poland, considering the obesity factor in particular

Olejniczak D, Bugajec D, Staniszewska A, Panczyk M, Kielan A, Czerw A, Mańczuk M, Juszczyk G, Skonieczna J, Brytek-Matera A

Neuropsychiatric Disease and Treatment 2018, 14:1521-1526

Published Date: 13 June 2018

The effect of evening primrose oil on fatigue and quality of life in patients with multiple sclerosis

Majdinasab N, Namjoyan F, Taghizadeh M, Saki H

Neuropsychiatric Disease and Treatment 2018, 14:1505-1512

Published Date: 12 June 2018

Electroencephalogram alpha asymmetry in patients with depressive disorders: current perspectives

Kaiser AK, Gnjezda MT, Knasmüller S, Aichhorn W

Neuropsychiatric Disease and Treatment 2018, 14:1493-1504

Published Date: 11 June 2018

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2

Sajatovic M, Ross R, Legacy SN, Byerly M, Kane JM, DiBiasi F, Fitzgerald H, Correll CU

Neuropsychiatric Disease and Treatment 2018, 14:1475-1492

Published Date: 8 June 2018

Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics – expert consensus survey part 1

Sajatovic M, Ross R, Legacy SN, Correll CU, Kane JM, DiBiasi F, Fitzgerald H, Byerly M

Neuropsychiatric Disease and Treatment 2018, 14:1463-1474

Published Date: 8 June 2018

Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics

Gui SW, Liu YY, Zhong XG, Liu XY, Zheng P, Pu JC, Zhou J, Chen JJ, Zhao LB, Liu LX, Xu GW, Xie P

Neuropsychiatric Disease and Treatment 2018, 14:1451-1461

Published Date: 6 June 2018

A review of ketamine’s role in ECT and non-ECT settings

Jankauskas V, Necyk C, Chue J, Chue P

Neuropsychiatric Disease and Treatment 2018, 14:1437-1450

Published Date: 6 June 2018

Misdiagnosed atypical paroxysmal kinesigenic dyskinesia: a case report

Pan F, Li S, Li H, Xu Y, Huang M

Neuropsychiatric Disease and Treatment 2018, 14:1433-1435

Published Date: 5 June 2018

Investigation on dysfunctional beliefs and attitudes about sleep in Chinese college students

Jin LR, Zhou J, Peng H, Ding SS, Yuan H

Neuropsychiatric Disease and Treatment 2018, 14:1425-1432

Published Date: 1 June 2018

Suicidality, self-stigma, social anxiety and personality traits in stabilized schizophrenia patients – a cross-sectional study

Vrbova K, Prasko J, Ociskova M, Holubova M, Kantor K, Kolek A, Grambal A, Slepecky M

Neuropsychiatric Disease and Treatment 2018, 14:1415-1424

Published Date: 1 June 2018

Memantine induces manic episode in a 73-year-old patient with vascular neurocognitive disorder: a case report

Duan JF, Lao CM, Chen JK, Pan F, Zhang CL, Xu WJ, Zhou WH, Hu JB, Shang DS, Huang ML, Xu Y

Neuropsychiatric Disease and Treatment 2018, 14:1395-1398

Published Date: 30 May 2018

Mothers and fathers of children with epilepsy: gender differences in post-traumatic stress symptoms and correlations with mood spectrum symptoms

Carmassi C, Corsi M, Bertelloni CA, Carpita B, Gesi C, Pedrinelli V, Massimetti G, Peroni DG, Bonuccelli A, Orsini A, Dell’Osso L

Neuropsychiatric Disease and Treatment 2018, 14:1371-1379

Published Date: 25 May 2018

Incidence of venous thromboembolism in psychiatric inpatients: a chart review

Takeshima M, Ishikawa H, Shimizu K, Kanbayashi T, Shimizu T

Neuropsychiatric Disease and Treatment 2018, 14:1363-1370

Published Date: 23 May 2018

Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study

Saragoussi D, Christensen MC, Hammer-Helmich L, Rive B, Touya M, Haro JM

Neuropsychiatric Disease and Treatment 2018, 14:1339-1350

Published Date: 22 May 2018

The characteristics of understanding of depression among older patients treated with antidepressants: a comparison between older and younger patients

Tomita T, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, Ishioka M, Nakamura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2018, 14:1319-1327

Published Date: 22 May 2018

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]

Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T

Neuropsychiatric Disease and Treatment 2018, 14:1307-1308

Published Date: 22 May 2018

Differences in psychopathology and behavioral characteristics of patients affected by conversion motor disorder and organic dystonia

Pastore A, Pierri G, Fabio G, Ferramosca S, Gigante A, Superbo M, Pellicciari R, Margari F

Neuropsychiatric Disease and Treatment 2018, 14:1287-1295

Published Date: 18 May 2018

Low dose of aripiprazole advanced sleep rhythm and reduced nocturnal sleep time in the patients with delayed sleep phase syndrome: an open-labeled clinical observation

Omori Y, Kanbayashi T, Sagawa Y, Imanishi A, Tsutsui K, Takahashi Y, Takeshima M, Takaki M, Nishino S, Shimizu T

Neuropsychiatric Disease and Treatment 2018, 14:1281-1286

Published Date: 18 May 2018

Harm avoidance and depression, anxiety, insomnia, and migraine in fifth-year medical students in Taiwan

Chen CY, Yu NW, Huang TH, Wang WS, Fang JT

Neuropsychiatric Disease and Treatment 2018, 14:1273-1280

Published Date: 16 May 2018

Synchronization within, and interactions between, the default mode and dorsal attention networks in relapsing-remitting multiple sclerosis

Huang M, Zhou F, Wu L, Wang B, Wan H, Li F, Zeng X, Gong H

Neuropsychiatric Disease and Treatment 2018, 14:1241-1252

Published Date: 14 May 2018

Disrupted interhemispheric functional connectivity in chronic insomnia disorder: a resting-state fMRI study

Zhou F, Zhao Y, Huang M, Zeng X, Wang B, Gong H

Neuropsychiatric Disease and Treatment 2018, 14:1229-1240

Published Date: 14 May 2018

Acupuncture in migraine prophylaxis in Czech patients: an open-label randomized controlled trial

Musil F, Pokladnikova J, Pavelek Z, Wang B, Guan X, Valis M

Neuropsychiatric Disease and Treatment 2018, 14:1221-1228

Published Date: 10 May 2018

Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review

Masopust J, Protopopová D, Vališ M, Pavelek Z, Klímová B

Neuropsychiatric Disease and Treatment 2018, 14:1211-1220

Published Date: 9 May 2018

Prefrontoparietal dysfunction during emotion regulation in anxiety disorder: a meta-analysis of functional magnetic resonance imaging studies

Wang HY, Zhang XX, Si CP, Xu Y, Liu Q, Bian HT, Zhang BW, Li XL, Yan ZR

Neuropsychiatric Disease and Treatment 2018, 14:1183-1198

Published Date: 9 May 2018

The impact of total sleep deprivation upon cognitive functioning in firefighters

Kujawski S, Słomko J, Tafil-Klawe M, Zawadka-Kunikowska M, Szrajda J, Newton JL, Zalewski P, Klawe JJ

Neuropsychiatric Disease and Treatment 2018, 14:1171-1181

Published Date: 8 May 2018

Children with autism spectrum disorders and selective mutism

Steffenburg H, Steffenburg S, Gillberg C, Billstedt E

Neuropsychiatric Disease and Treatment 2018, 14:1163-1169

Published Date: 7 May 2018

The effects of Maras powder use on patients with migraine

İnanç Y, Orhan FÖ, İnanç Y

Neuropsychiatric Disease and Treatment 2018, 14:1143-1148

Published Date: 7 May 2018

Allergy to chlorpromazine and valproic acid following carbamazepine hypersensitivity in a patient with an HLA-B*4601 allele

Sakurada K, Kozaru T, Yamada K, Nibuya M, Nagata K, Suzuki E

Neuropsychiatric Disease and Treatment 2018, 14:1139-1142

Published Date: 4 May 2018

Antidopaminergic medication in healthy subjects provokes subjective and objective mental impairments tightly correlated with perturbation of biogenic monoamine metabolism and prolactin secretion

Veselinović T, Vernaleken I, Cumming P, Henning U, Winkler L, Kaleta P, Paulzen M, Luckhaus C, Gründer G

Neuropsychiatric Disease and Treatment 2018, 14:1125-1138

Published Date: 27 April 2018

Antidepressant medication use and nasopharyngeal cancer risk: a nationwide population-based study

Lin C, Chan HL, Hsieh YH, Liang H, Chiu WC, Lee Y, McIntyre RS, Chen VC

Neuropsychiatric Disease and Treatment 2018, 14:1101-1106

Published Date: 30 April 2018

New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab

Frau J, Coghe G, Lorefice L, Fenu G, Cocco E

Neuropsychiatric Disease and Treatment 2018, 14:1093-1099

Published Date: 23 April 2018

Comparison of changes in oxygenated hemoglobin during the tree-drawing task between patients with schizophrenia and healthy controls

Nakano S, Shoji Y, Morita K, Igimi H, Sato M, Ishii Y, Kondo A, Uchimura N

Neuropsychiatric Disease and Treatment 2018, 14:1071-1082

Published Date: 20 April 2018

Aberrant brain functional connectome in patients with obstructive sleep apnea

Chen L, Fan X, Li H, Ye C, Yu H, Xin H, Gong H, Peng D, Yan L

Neuropsychiatric Disease and Treatment 2018, 14:1059-1070

Published Date: 18 April 2018

Electroconvulsive therapy in 77-year-old patient with pacemaker: a case report

Mędrala T, Pycińska A, Pyciński B, Merk W, Kucia K

Neuropsychiatric Disease and Treatment 2018, 14:1055-1058

Published Date: 17 April 2018

Significant association of BDNF rs6265 G>A polymorphism with susceptibility to epilepsy: a meta-analysis

Xu Y, Li X, Zhuang S, Guo S, Xiang J, Wang L, Zhou L, Wu B

Neuropsychiatric Disease and Treatment 2018, 14:1035-1046

Published Date: 16 April 2018

Does higher severity really correlate with a worse quality of life in obsessive–compulsive disorder? A meta-regression

Pozza A, Lochner C, Ferretti F, Cuomo A, Coluccia A

Neuropsychiatric Disease and Treatment 2018, 14:1013-1023

Published Date: 16 April 2018

Metabolite-related antidepressant action of diterpene ginkgolides in the prefrontal cortex

Hu Q, Shen P, Bai S, Dong M, Liang Z, Chen Z, Wang W, Wang H, Gui S, Li P, Xie P

Neuropsychiatric Disease and Treatment 2018, 14:999-1011

Published Date: 13 April 2018

The functional and structural characteristics of the emotion network in alexithymia

Han D, Li M, Mei MJ, Sun XF

Neuropsychiatric Disease and Treatment 2018, 14:991-998

Published Date: 12 April 2018

The effects of psychoeducational family intervention on coping strategies of relatives of patients with bipolar I disorder: results from a controlled, real-world, multicentric study

Sampogna G, Luciano M, Del Vecchio V, Malangone C, De Rosa C, Giallonardo V, Borriello G, Pocai B, Savorani M, Steardo L Jr, Lampis D, Veltro F, Bartoli F, Bardicchia F, Moroni AM, Ciampini G, Orlandi E, Ferrari S, Biondi S, Iapichino S, Pompili E, Piselli M, Tortorella A, Carrà G, Fiorillo A

Neuropsychiatric Disease and Treatment 2018, 14:977-989

Published Date: 11 April 2018

Insomnia in hospitalized psychiatric patients: prevalence and associated factors

Talih F, Ajaltouni J, Ghandour H, Abu-Mohammad AS, Kobeissy F

Neuropsychiatric Disease and Treatment 2018, 14:969-975

Published Date: 10 April 2018

Prospective interepisodal mood monitoring in patients with affective disorders: a feasibility study [Corrigendum]

Van der Watt ASJ, Suryapranata APSP, Seedat S

Neuropsychiatric Disease and Treatment 2018, 14:967-968

Published Date: 10 April 2018

Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study

Otsubo T, Watanabe Y, Hongo S, Inoue M, Akimoto K, Murakami K, Takahashi R, Kikuchi T

Neuropsychiatric Disease and Treatment 2018, 14:955-966

Published Date: 6 April 2018

Elevated peripheral blood glutamate levels in major depressive disorder

Inoshita M, Umehara H, Watanabe S, Nakataki M, Kinoshita M, Tomioka Y, Tajima A, Numata S, Ohmori T

Neuropsychiatric Disease and Treatment 2018, 14:945-953

Published Date: 6 April 2018

Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats

Kanada Y, Katayama A, Ikemoto H, Takahashi K, Tsukada M, Nakamura A, Ishino S, Hisamitsu T, Sunagawa M

Neuropsychiatric Disease and Treatment 2018, 14:937-944

Published Date: 6 April 2018

Investigation of variants in estrogen receptor genes and perinatal depression

Tan EC, Lim HW, Chua TE, Tan HS, Lee TMY, Chen HY

Neuropsychiatric Disease and Treatment 2018, 14:919-925

Published Date: 29 March 2018

Ten-year outcome of vagus nerve stimulation-implanted patients with treatment-resistant depression: two Italian cases

Dell'Osso B, Oldani L, Grancini B, Dario A, Altamura AC

Neuropsychiatric Disease and Treatment 2018, 14:915-918

Published Date: 29 March 2018

Psychometric properties of the Patient Dignity Inventory in an acute psychiatric ward: an extension study of the preliminary validation

Di Lorenzo R, Ferri P, Biffarella C, Cabri G, Carretti E, Pollutri G, Spattini L, Del Giovane C, Chochinov HM

Neuropsychiatric Disease and Treatment 2018, 14:903-913

Published Date: 29 March 2018

Serum levels of GPER -1 in euthymic bipolar patients

Orhan FÖ, Kurutaş EB, Doğaner A, Türker E, Taner Özcü SŞ, Güngör M, Çakmak S

Neuropsychiatric Disease and Treatment 2018, 14:855-862

Published Date: 26 March 2018

Aberrant regional brain activities in alcohol dependence: a functional magnetic resonance imaging study

Tu XZ, Wang JJ, Liu XM, Zheng JY

Neuropsychiatric Disease and Treatment 2018, 14:847-853

Published Date: 22 March 2018

Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson’s disease

Hauser RA, Ellenbogen A, Khanna S, Gupta S, Modi NB

Neuropsychiatric Disease and Treatment 2018, 14:839-845

Published Date: 22 March 2018

Continuous performance task in ADHD: Is reaction time variability a key measure?

Levy F, Pipingas A, Harris EV, Farrow M, Silberstein RB

Neuropsychiatric Disease and Treatment 2018, 14:781-786

Published Date: 15 March 2018

Association between etiology and lesion site in ischemic brainstem infarcts: a retrospective observational study

Baran G, Ozdemir Gultekin T, Baran O, Deniz C, Katar S, Babacan Yildiz G, Asil T

Neuropsychiatric Disease and Treatment 2018, 14:757-766

Published Date: 13 March 2018

Repetitive transcranial magnetic stimulation for the treatment of cognitive impairment in frontotemporal dementia: an open-label pilot study

Antczak J, Kowalska K, Klimkowicz-Mrowiec A, Wach B, Kasprzyk K, Banach M, Rzeźnicka-Brzegowy K, Kubica J, Słowik A

Neuropsychiatric Disease and Treatment 2018, 14:749-755

Published Date: 13 March 2018

Novel treatment options in depression and psychosis

Ceskova E, Silhan P

Neuropsychiatric Disease and Treatment 2018, 14:741-747

Published Date: 13 March 2018

Secondary central nervous system lymphoma: spectrum of morphological MRI appearances

Malikova H, Burghardtova M, Koubska E, Mandys V, Kozak T, Weichet J

Neuropsychiatric Disease and Treatment 2018, 14:733-740

Published Date: 12 March 2018

Efficacy, tolerability, and safety of oral paliperidone extended release in the treatment of schizophrenia: a 24-week, open-label, prospective switch study in different settings in Taiwan

Chen CY, Tang TC, Chen TT, Bai YM, Tsai HH, Chen HL, Huang CJ, Chen CK, Chen CC, Hsiao MC, Liu CY, Yeh HS, Chiu NY, Hsiao CC, Chen CS, Su TP

Neuropsychiatric Disease and Treatment 2018, 14:725-732

Published Date: 8 March 2018

Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response

Zeng D, He S, Yu S, Li G, Ma C, Wen Y, Shen Y, Yu Y, Li H

Neuropsychiatric Disease and Treatment 2018, 14:715-723

Published Date: 8 March 2018

Aggressiveness, violence, homicidality, homicide, and Lyme disease

Bransfield RC

Neuropsychiatric Disease and Treatment 2018, 14:693-713

Published Date: 9 March 2018

The utility of novel outcome measures in a naturalistic evaluation of schizophrenia treatment

Tompsett T, Masters K, Donyai P

Neuropsychiatric Disease and Treatment 2018, 14:681-691

Published Date: 2 March 2018

Evaluating psychiatric readmissions in the emergency department of a large public hospital

Morris DW, Ghose S, Williams E, Brown K, Khan F

Neuropsychiatric Disease and Treatment 2018, 14:671-679

Published Date: 1 March 2018

A cross-sectional study exploring useful indicators for low bone mineral density in male alcoholic patients

Horai T, Hishimoto A, Otsuka I, So T, Mouri K, Shimmyo N, Boku S, Okishio N, Sora I

Neuropsychiatric Disease and Treatment 2018, 14:663-669

Published Date: 28 February 2018

Sex differences in gut microbiota in patients with major depressive disorder

Chen JJ, Zheng P, Liu YY, Zhong XG, Wang HY, Guo YJ, Xie P

Neuropsychiatric Disease and Treatment 2018, 14:647-655

Published Date: 26 February 2018

Childhood trauma and dissociation among women with genito-pelvic pain/penetration disorder

Özen B, Özdemir YO, Beştepe EE

Neuropsychiatric Disease and Treatment 2018, 14:641-646

Published Date: 23 February 2018

Pediatric-onset multiple sclerosis in Egypt: a multi-center registry of 186 patients

Hamdy SM, Abdel-Naseer M, Shalaby NM, Elmazny A, Girgis M, Nada MA, Hassan A, Mourad HS, Hegazy MI, Abdelalim A, Kishk NA, Abokrysha NT, Genedy SA, Essawy EA, Shehata HS

Neuropsychiatric Disease and Treatment 2018, 14:631-640

Published Date: 23 February 2018

Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine

Imagawa H, Nagar SP, Montgomery W, Nakamura T, Sato M, Davis KL

Neuropsychiatric Disease and Treatment 2018, 14:611-621

Published Date: 22 February 2018

IQ discrepancy differentiates levels of fine motor skills and their relationship in children with autism spectrum disorders

Yu TY, Chou W, Chow JC, Lin CH, Tung LC, Chen KL

Neuropsychiatric Disease and Treatment 2018, 14:597-605

Published Date: 20 February 2018

Vitamin D and vitamin D receptor levels in children with attention-deficit/hyperactivity disorder

Sahin N, Altun H, Kurutas EB, Balkan D

Neuropsychiatric Disease and Treatment 2018, 14:581-585

Published Date: 19 February 2018

Drug–drug interactions involving antidepressants: focus on desvenlafaxine

Low Y, Setia S, Lima G

Neuropsychiatric Disease and Treatment 2018, 14:567-580

Published Date: 19 February 2018

Human factors evaluation of a novel digital medicine system in psychiatry

Peters-Strickland T, Hatch A, Adenwala A, Atkinson K, Bartfeld B

Neuropsychiatric Disease and Treatment 2018, 14:553-565

Published Date: 16 February 2018

Prospective interepisodal mood monitoring in patients with affective disorders: a feasibility study

Van der Watt ASJ, Suryapranata APSP, Seedat S

Neuropsychiatric Disease and Treatment 2018, 14:517-524

Published Date: 14 February 2018

Corpus callosum infarction with cognitive dysfunction: two case reports and literature review

Zhang J, Tang Y, Sun Y, Xu Y, Pang L, Li J, Wu T, He M

Neuropsychiatric Disease and Treatment 2018, 14:511-515

Published Date: 13 February 2018

Timing of psychoeducation for patients with depression who were treated with antidepressants: when should patients receive psychoeducation

Tomita T, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, Ishioka M, Nakamura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2018, 14:505-510

Published Date: 12 February 2018

Glia maturation factor-β: a potential therapeutic target in neurodegeneration and neuroinflammation

Fan J, Fong T, Chen X, Chen C, Luo P, Xie H

Neuropsychiatric Disease and Treatment 2018, 14:495-504

Published Date: 9 February 2018

The effect of exercise on cancer-related fatigue in cancer survivors: a systematic review and meta-analysis

Kessels E, Husson O, van der Feltz-Cornelis CM

Neuropsychiatric Disease and Treatment 2018, 14:479-494

Published Date: 9 February 2018

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness

Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T

Neuropsychiatric Disease and Treatment 2018, 14:451-457

Published Date: 8 February 2018

Suicidal drug overdose following stroke in elderly patients: a retrospective population-based cohort study

Chang CH, Chen SJ, Liu CY, Tsai HC

Neuropsychiatric Disease and Treatment 2018, 14:443-450

Published Date: 7 February 2018

The differences between patients with panic disorder and healthy controls in psychophysiological stress profile

Kotianova A, Kotian M, Slepecky M, Chupacova M, Prasko J, Tonhajzerova I

Neuropsychiatric Disease and Treatment 2018, 14:435-441

Published Date: 7 February 2018

Cognitive behavioral group therapy versus psychoeducational intervention in Parkinson’s disease

Berardelli I, Bloise MC, Bologna M, Conte A, Pompili M, Lamis DA, Pasquini M, Fabbrini G

Neuropsychiatric Disease and Treatment 2018, 14:399-405

Published Date: 26 January 2018

Color preferences in participants with high or low hypnotic susceptibility

Yu E, Zhu J, Tan Y, Liao Z, Qiu Y, Zhang B, Wang C, Wang W

Neuropsychiatric Disease and Treatment 2018, 14:393-398

Published Date: 30 January 2018

Self-stigma and treatment effectiveness in patients with anxiety disorders – a mediation analysis

Ociskova M, Prasko J, Vrbova K, Kasalova P, Holubova M, Grambal A, Machu K

Neuropsychiatric Disease and Treatment 2018, 14:383-392

Published Date: 26 January 2018

Adjustment disorder: current perspectives

Zelviene P, Kazlauskas E

Neuropsychiatric Disease and Treatment 2018, 14:375-381

Published Date: 25 January 2018

Oxidative/antioxidative status, lymphocyte DNA damage, and urotensin-2 receptor level in patients with migraine attacks

Yigit M, Sogut O, Tataroglu Ö, Yamanoglu A, Yigit E, Guler EM, Ozer OF, Kocyigit A

Neuropsychiatric Disease and Treatment 2018, 14:367-374

Published Date: 24 January 2018

The impact of age of onset on amygdala intrinsic connectivity in major depression

Clark DL, Konduru N, Kemp A, Bray S, Brown EC, Goodyear B, Ramasubbu R

Neuropsychiatric Disease and Treatment 2018, 14:343-352

Published Date: 22 January 2018

Reflex epilepsy: triggers and management strategies

Okudan ZV, Özkara Ç

Neuropsychiatric Disease and Treatment 2018, 14:327-337

Published Date: 18 January 2018

Systematic review of catatonia treatment

Pelzer ACM, van der Heijden FMMA, den Boer E

Neuropsychiatric Disease and Treatment 2018, 14:317-326

Published Date: 17 January 2018

“Low road” to rehabilitation: a perspective on subliminal sensory neuroprosthetics

Ghai S, Ghai I, Effenberg AO

Neuropsychiatric Disease and Treatment 2018, 14:301-307

Published Date: 17 January 2018

ADHD and lifestyle habits in Czech adults, a national sample

Weissenberger S, Ptacek R, Vnukova M, Raboch J, Klicperova-Baker M, Domkarova L, Goetz M

Neuropsychiatric Disease and Treatment 2018, 14:293-299

Published Date: 15 January 2018

Impact of intravenous thrombolysis on length of hospital stay in cases of acute ischemic stroke

Kasemsap N, Vorasoot N, Kongbunkiat K, Peansukwech U, Tiamkao S, Sawanyawisuth K

Neuropsychiatric Disease and Treatment 2018, 14:259-264

Published Date: 9 January 2018

Altered intrinsic brain activities in patients with acute eye pain using amplitude of low-frequency fluctuation: a resting-state fMRI study

Pan Z, Li H, Bao J, Jiang N, Yuan Q, Freeberg S, Zhu P, Ye L, Ma M, Huang X, Shao Y

Neuropsychiatric Disease and Treatment 2018, 14:251-257

Published Date: 9 January 2018

Functional impairment in patients with major depressive disorder: the 2-year PERFORM study

Hammer-Helmich L, Haro JM, Jönsson B, Tanguy Melac A, Di Nicola S, Chollet J, Milea D, Rive B, Saragoussi D

Neuropsychiatric Disease and Treatment 2018, 14:239-249

Published Date: 9 January 2018

Anxiety and depression in paradoxical insomnia: a case–control study

Liao J, Zhu S, Li X

Neuropsychiatric Disease and Treatment 2018, 14:231-238

Published Date: 8 January 2018

Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings

Maciel A, Cullors A, Lukowiak AA, Garces J

Neuropsychiatric Disease and Treatment 2018, 14:225-230

Published Date: 8 January 2018

Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study

Introna A, D'Errico E, Modugno B, Scarafino A, Fraddosio A, Distaso E, Tempesta I, Mastronardi A, Simone IL

Neuropsychiatric Disease and Treatment 2018, 14:193-203

Published Date: 4 January 2018

Low level of knowledge regarding diagnosis and treatment among inpatients with schizophrenia in Shanghai

Huang J, Chiovenda A, Shao Y, Ma H, Li H, Good MJDV

Neuropsychiatric Disease and Treatment 2018, 14:185-191

Published Date: 4 January 2018

Diagnostic challenges in multiple system atrophy

Obelieniene D, Bauzaite S, Kulakiene I, Keleras E, Eitmonaite I, Rastenyte D

Neuropsychiatric Disease and Treatment 2018, 14:179-184

Published Date: 4 January 2018

The current status of culturally adapted mental health interventions: a practice-focused review of meta-analyses

Rathod S, Gega L, Degnan A, Pikard J, Khan T, Husain N, Munshi T, Naeem F

Neuropsychiatric Disease and Treatment 2018, 14:165-178

Published Date: 4 January 2018

A meta-analysis of data associating DRD4 gene polymorphisms with schizophrenia

Xu F, Wu X, Zhang J, Wang B, Yao J

Neuropsychiatric Disease and Treatment 2018, 14:153-164

Published Date: 3 January 2018

Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies

Weiller E, Weiss C, Watling CP, Edge C, Hobart M, Eriksson H, Fava M

Neuropsychiatric Disease and Treatment 2018, 14:103-115

Published Date: 29 December 2017

Changes of serum uric acid and total bilirubin in elderly patients with major postischemic stroke depression

Gao J, Xu W, Han K, Zhu L, Gao L, Shang XL

Neuropsychiatric Disease and Treatment 2018, 14:83-93

Published Date: 27 December 2017

Quality of life and coping strategies of outpatients with a depressive disorder in maintenance therapy – a cross-sectional study

Holubova M, Prasko J, Ociskova M, Grambal A, Slepecky M, Marackova M, Kamaradova D, Zatkova M

Neuropsychiatric Disease and Treatment 2018, 14:73-82

Published Date: 22 December 2017

An acute bout of housework activities has beneficial effects on executive function

Tsuchiya K, Mitsui S, Fukuyama R, Yamaya N, Fujita T, Shimoda K, Tozato F

Neuropsychiatric Disease and Treatment 2018, 14:61-72

Published Date: 22 December 2017

Plasma complement component 4 increases in patients with major depressive disorder

Wei J, Liu Y, Zhao L, Yang X, Ni P, Wang Y, Li T, Ma X

Neuropsychiatric Disease and Treatment 2018, 14:37-41

Published Date: 20 December 2017

Migraine in young females with irritable bowel syndrome: still a challenge

Georgescu D, Reisz D, Gurban CV, Georgescu LA, Ionita I, Ancusa OE, Lighezan D

Neuropsychiatric Disease and Treatment 2018, 14:21-28

Published Date: 20 December 2017

Brain functional integration: an epidemiologic study on stress-producing dissociative phenomena

Sperandeo R, Monda V, Messina G, Carotenuto M, Maldonato NM, Moretto E, Leone E, De Luca V, Monda M, Messina A

Neuropsychiatric Disease and Treatment 2018, 14:11-19

Published Date: 19 December 2017